Repligen | RGEN - Себестоимость





Себестоимость Изменить Дата
Agilent USD 845M 7M 2026-03
Align Technology USD 298.76M 4.74M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Bruker USD 422.5M 21.1M 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
General Electric Aerospace USD 8.89B 736M 2026-06
Henry Schein USD 2.43B 129M 2026-06
Illumina USD 389M 19M 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pfizer USD 4.09B 498M 2026-06
Repligen USD 94.09M 8.12M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Standard Biotools USD 9.84M 2.58M 2026-03
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Waters USD 1.16B 430M 2026-06
West Pharmaceutical Services USD 543.1M 5.4M 2026-06